Seeking AlphaThu, 18 Jun 2026 03:42:09 GMTOcular Therapeutix, Inc. (OCUL) Analyst/Investor Day TranscriptOCUL-3.23%
BenzingaWed, 17 Jun 2026 14:55:03 GMTOcular Therapeutix Maps Regulatory Strategy For Lead Drug ProgramOCUL-3.23%
The Motley FoolMon, 15 Jun 2026 20:10:02 GMTOcular Therapeutix vs. Prime Medicine: Which Healthcare Stock Is a Better Buy in 2026?OCUL-3.23%
Seeking AlphaWed, 13 May 2026 02:00:46 GMTOcular Therapeutix, Inc. (OCUL) Presents at Bank of America Global Healthcare Conference 2026 TranscriptOCUL-3.23%
Seeking AlphaTue, 05 May 2026 18:41:15 GMTOcular Therapeutix, Inc. (OCUL) Q1 2026 Earnings Call TranscriptOCUL-3.23%
Zacks Investment ResearchTue, 05 May 2026 14:16:00 GMTOcular Therapeutix (OCUL) Reports Q1 Loss, Misses Revenue EstimatesOCUL-3.23%